AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CBD spray calms Alzheimer's anxiety? early trial hints at relief
Symptom relief OngoingThis small, early-stage study tested a high-CBD, low-THC liquid spray for 8 weeks in 12 older adults with mild cognitive impairment or mild-to-moderate Alzheimer's who also had significant anxiety or agitation. The goal was to see if the treatment could reduce these behavioral sy…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: EARLY_PHASE1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Real-World safety check for agitation inhaler
Knowledge-focused TerminatedThis study observes the safety of ADASUVE (loxapine inhalation) in up to 10,000 adults with agitation from schizophrenia or bipolar I disorder. It tracks side effects in real-world emergency or inpatient settings. The study is observational, meaning no new treatment is given—just…
Matched conditions: AGITATION,PSYCHOMOTOR
Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC